Revolutionary Therapeutics – Utilising Personalised Medicine to Treat Cancer

Prof. Dan Peer is the Vice President for R&D at Tel Aviv University, Director of the Laboratory of Precision NanoMedicine and Chair of TAU Cancer Biology Research Center. His lab works in the interface of basic and translational science and Prof. Peer has more than 120 pending and granted patents.